MGNX
Price:
$4.13
Market Cap:
$262.52M
MacroGenics, Inc. is a U.S.-based biopharmaceutical company specializing in the development and commercialization of antibody-derived treatments primarily aimed at combating cancer. The company's sole approved product is MARGENZA (margetuximab-cmkb). This drug acts as an antagonist to the human epidermal growth factor receptor 2 (HER2) and is prescribed in conjunction with chemotherapy for adult patients suffering from metastatic HER2-positive breast cancer who have previously undergone at least two different anti-HER2 treatment regimens. Beyond its commercialized medicine, MacroGenics boasts an extensive pipeline of investigational immuno-oncology therapies. These include: MGC018, an antibo...[Read more]
Industry
Biotechnology
IPO Date
2013-10-10
Stock Exchange
NASDAQ
Ticker
MGNX
According to MacroGenics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.90. This represents a change of -56.46% compared to the average of 4.37 of the last 4 quarters.
The mean historical Current Ratio of MacroGenics, Inc. over the last ten years is 5.47. The current 1.90 Current Ratio has changed 3.38% with respect to the historical average. Over the past ten years (40 quarters), MGNX's Current Ratio was at its highest in in the June 2016 quarter at 17.84. The Current Ratio was at its lowest in in the March 2026 quarter at 1.90.
Average
5.47
Median
4.84
Minimum
3.75
Maximum
10.40
Discovering the peaks and valleys of MacroGenics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.25%
Maximum Annual Current Ratio = 10.40
Minimum Annual Increase = -39.23%
Minimum Annual Current Ratio = 3.75
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.10 | 30.25% |
| 2024 | 3.92 | -12.57% |
| 2023 | 4.48 | -1.99% |
| 2022 | 4.57 | 21.93% |
| 2021 | 3.75 | -39.23% |
| 2020 | 6.17 | 16.20% |
| 2019 | 5.31 | 18.24% |
| 2018 | 4.49 | -30.69% |
| 2017 | 6.48 | -37.72% |
| 2016 | 10.40 | -29.26% |
The current Current Ratio of MacroGenics, Inc. (MGNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.50
5-year avg
4.36
10-year avg
5.47
MacroGenics, Inc.’s Current Ratio is less than Ovid Therapeutics Inc. (10.17), less than Context Therapeutics Inc. (8.96), less than Clene Inc. (1.94), less than Whitehawk Therapeutics Inc (11.36), less than Shattuck Labs, Inc. (22.06), less than Connect Biopharma Holdings Limited (3.74), less than Oramed Pharmaceuticals Inc. (6.45), less than Zentalis Pharmaceuticals, Inc. (6.19), less than Coya Therapeutics, Inc. (15.02), less than InflaRx N.V. (4.16),
| Company | Current Ratio | Market cap |
|---|---|---|
| 10.17 | $299.38M | |
| 8.96 | $58.06M | |
| 1.94 | $61.95M | |
| 11.36 | $218.58M | |
| 22.06 | $237.12M | |
| 3.74 | $125.93M | |
| 6.45 | $158.79M | |
| 6.19 | $263.39M | |
| 15.02 | $89.59M | |
| 4.16 | $130.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MacroGenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MacroGenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is MacroGenics, Inc.'s Current Ratio?
How is the Current Ratio calculated for MacroGenics, Inc. (MGNX)?
What is the highest Current Ratio for MacroGenics, Inc. (MGNX)?
What is the 3-year average Current Ratio for MacroGenics, Inc. (MGNX)?
What is the 5-year average Current Ratio for MacroGenics, Inc. (MGNX)?
How does the current Current Ratio for MacroGenics, Inc. (MGNX) compare to its historical average?